MAPT and Alzheimer disease: Alzheimer’s disease (AD) stands as one of the most pressing challenges in neurodegenerative disorders, characterized by a relentless decline in cognitive function and the accumulation of pathological proteins such as Amyloid-Beta (Aβ) plaques and hyperphosphorylated tau tangles [23,24,25,26,27,28].